By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Concert Pharmaceuticals, Inc. 

99 Hayden Avenue
Suite 500
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-860-0045 Fax: n/a



Start Up

Company News
Concert Pharma (CNCE) Announces $30 Million Venture Debt Financing From Hercules Capital 6/12/2017 7:27:13 AM
Concert Pharma (CNCE) Announces Departure Of Chief Financial Officer, Ryan Daws 5/30/2017 6:05:54 AM
Concert Pharma (CNCE) Announces Shareholder Approval Of CTP-656 Asset Purchase Agreement With Vertex (VRTX) 5/24/2017 9:17:40 AM
Concert Pharma (CNCE) Receives Second Request From FTC Under HSR Act 5/22/2017 6:12:18 AM
FDA Slaps Clinical Hold on Concert Pharma (CNCE)'s Hair Loss Drug 5/17/2017 5:54:20 AM
Concert Pharma (CNCE) Initiates CTP-543 Phase II Trial In Alopecia Areata 5/2/2017 6:17:38 AM
Concert Pharma (CNCE) Reports First Quarter 2017 Financial Results 5/2/2017 6:10:30 AM
Concert Pharma (CNCE) To Report First Quarter 2017 Financial Results On May 2, 2017, And Present At Upcoming Investor Conferences 4/25/2017 6:14:11 AM
Filings Reveal Concert Pharma (CNCE) Spurned $250 Million Buyout Offer From Vertex (VRTX) in November 2016 3/26/2017 8:36:39 PM
Vertex (VRTX) To Acquire CTP-656 From Concert Pharma (CNCE) For The Treatment Of Cystic Fibrosis 3/6/2017 7:01:46 AM